Mylan to start Phase III trial of generic Advair Diskus, insulin analogue to Lantus

Global generic and specialty pharmaceuticals company Mylan is set to start a Phase III clinical trial of its generic version of GlaxoSmithKline's (GSK) Advair Diskus and its insulin analogue to Sanofi's Lantus.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news